June 12, 2012
The Subcommittee on Long-listed Drugs of the Federation of Pharmaceutical Manufacturers’ Associations of Japan’s (FPMAJ) NHI Drug Price Study Committee issued a report on June 8 that criticizes the ad hoc price reduction for long-listed drugs carried out in this...read more